Community Health Systems (CYH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 11,789,000 | 13,210,000 | 14,155,000 | 15,353,000 | 18,438,000 |
| Cost of Goods | 1,963,000 | 2,151,000 | 2,355,000 | 2,672,000 | 3,011,000 |
| Gross Profit | 9,826,000 | 11,059,000 | 11,800,000 | 12,681,000 | 15,427,000 |
| Operating Expenses | 8,700,000 | 10,409,000 | 11,592,000 | 14,559,000 | 16,287,000 |
| Operating Income | 1,126,000 | 650,000 | 208,000 | -1,878,000 | -860,000 |
| Interest Expense | 1,031,000 | 1,041,000 | 976,000 | 931,000 | 962,000 |
| Other Income | 327,000 | -39,000 | 53,000 | -24,000 | 107,000 |
| Pre-tax Income | 422,000 | -430,000 | -715,000 | -2,833,000 | -1,715,000 |
| Income Tax | -185,000 | 160,000 | -11,000 | -449,000 | -104,000 |
| Net Income Continuous | 607,000 | -590,000 | -704,000 | -2,384,000 | -1,611,000 |
| Net Income Discontinuous | N/A | N/A | N/A | -12,000 | -15,000 |
| Minority Interests | 96,000 | 85,000 | 84,000 | 63,000 | 95,000 |
| Net Income | $511,000 | $-675,000 | $-788,000 | $-2,459,000 | $-1,721,000 |
| EPS Basic Total Ops | 4.43 | -5.93 | -6.99 | -22.00 | -15.54 |
| EPS Basic Continuous Ops | 5.26 | -5.19 | -6.25 | -21.89 | -15.41 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.11 | -0.13 |
| EPS Diluted Total Ops | 4.39 | -5.93 | -6.99 | -22.00 | -15.54 |
| EPS Diluted Continuous Ops | 5.21 | -5.19 | -6.25 | -21.89 | -15.41 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.11 | -0.13 |
| EPS Diluted Before Non-Recurring Items | 0.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,684,000 | $1,258,000 | $908,000 | $-1,017,000 | $240,000 |